A good read for people who are new to investing https://www.amazon.com/gp/product/1477463992/ref=as_li_tl?ie=UTF8&tag=investorpalac-20&camp=1789&creative=9325&linkCode=as2&creativeASIN=1477463992&linkId=f45153e24ca65b45b5669067dd74161b
Let me know if I missed any relevant companies. This is only a list of medical/research companies so growers and retailers are not included.
CMM Canabo Medical Inc – 29 Million – Owns and operates Medical Marijuana Clinics in Canada. Expanding at a good pace and projected to be profitable in 2017.
CARA Cara Therapeutics Inc – 500 Million – Researching cannabinoid based medicine to deal with pain and pruritus. Has been issued several patents related to their research.
GWPH GW Pharmaceuticals – 3.3 Billion – Research company that already Sativex approved to treat multiple sclerosis spasticity along with several other medicines in clinical trial phases. Has a deep pipeline of cannabinoid products and is currently the biggest company that is involved in Marijuana research.
ZYNE Zynerba Pharmaceuticals Inc – 270 Million – Research company that currently has 2 cannabinoid based medicines that are being tested on 5 conditions. Phase 2 Clinical trials going to be coming out in mid 2017.
INSY Insys Therapeutics Inc – 790 Million – Research company that already has products developed as well as several cannabinoid products in phase 2 clinical trials. One of the few companies that is researching marijuana based medicine that is making money instead of losing it.
AXIM AXIM Biotechnologies Inc – 450 Million – Researching several different cannabinoid based medicines with several of them being in clinical trials. Currently 43% owned by MJNA.
OWCP OWC Pharmaceutical Research Corp – 150 Million – Research company that is currently developing a cannabinoid Psoriasis treatment cream as well as planning to develop other medicines soon. It has a high volatility so be warned.
KALY Kalytera Therapeutics Inc – 70 Million – Early stage research company that is currently focusing on Graft versus Host Disease but will focus on other conditions later on. Small cap company which has potential to grow significantly in the future.
RVV Revive Therapeutics – 13 Million – Early stage research company that is targeting Kidney Stones and Gout. High risk but high reward company that could grow significantly if something important is discovered by them.
IMLFF InMed Pharmaceuticals Inc. – 30 Million – Small research company which recently filed for a patent.
CRBP Corbus Pharmaceuticals Holdings Inc – 430 Million – A research company that had some major developments in 2016, yielding investors high returns.
ABBV AbbVie Inc. – 101 Billion – A giant pharmaceutical company that has plenty of money top sink some into Marijuana research, and it is.
CNBX Cannabics Pharmaceuticals Inc – 290 Million – Does cannabinoid scientific research to create therapies for cancer patients.
THC THC Biomed Intl Ltd – 82 Million – A company focused on providing precise scientific information on growing marijuana as well providing seeds/plants with precise consistency and quality.
PMCB Pharmacyte Biotech Inc – 90 Million – A smaller research company that is focusing on treatments of hard to treat cancers with cannabinoid technology.
CVSI CV Sciences Inc – 23 Million – A very small research company that is currently working on “chewing gum containing nicotine and synthetic CBD to support cessation of smokeless tobacco use and addiction”.